(Date:11/9/2009)...E MARY, Fla., Nov. 9 Access MediQu...f outsourced implantable medical device management...oday that it is relocating its corporate headquart...the firm,s continued rapid growth, includes a majo...space that will open in January 2010 and relocatio...
(Date:11/9/2009)... ARBOR, Mich., Nov. 9 Thomson Re...al Xpert(TM) CareFocus, a leading clinical surveil...at-risk patients in real-time and respond immediat...ost of treatment. ,, This upgrade is available ...st. ,, CareFocus 2.0 contains several powerfu...
(Date:11/9/2009)...LADELPHIA, Nov. 9 Shir...ecialty biopharmaceutical company, today announced...Extended Release Tablets in pharmacies across the ...it/Hyperactivity Disorder ( ADHD ) in children a...y formulation of guanfacine, is the first and only...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7RSB Spine LLC Announces FDA Clearance for the InterPlate 28R 29 C Ti as an Anterior Cervical Plate 5399 1AvMed Covers H1N1 Flu Vaccine For Members 5395 1AvMed Covers H1N1 Flu Vaccine For Members 5395 2Stop Smoking Vaccine in the Works 59295 1Stop Smoking Vaccine in the Works 59295 2...ized, Double-Blind Study Targets Biomarker-Defined...ta,Incorporated (Nasdaq: GNTA ) announced that th...,s confirmatory Phase 3 trial of Genasense,(oblime...rial, known as,AGENDA, is a randomized, double-bli... randomly assigned to receive Genasense plus dacar...
...EGO, Aug. 20 Lpath, Inc. (OTC Bulletin,Board: LPT...nst bioactive,lipids, reported that a standard pan... humanized version of Sphingomab(TM), and the find...g of the antibody to humans. Sphingomab, generate...hnology, is a monoclonal antibody against the bioa...
Other Medicine Technology:Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 2Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 3Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 4Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma 5Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates 2Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates 3Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates 4(Date:11/9/2009)... Fast food chains are ofte...sity. A recent poll by Fitness.com.au however find...ulder the responsibility. , ... food chains, and video games were behind Australi...Dad are more than just innocent bystanders. A rece...
(Date:11/9/2009)..., The National Comprehensive Cancer Network (NC...ent that details a draft paradigm for near-term co... upon existing data. The document introduces the N...sensus-based process that compares the risk-versus...d in the NCCN Clinical Practice Guidelines in Onco...
(Date:11/9/2009)..., CHICAGO, Nov. 9 Highlighting ...titutions with advanced entertainment and digital ...casing its latest Long-Term Care and Hospital Grad...and Services for the Aging 2009 annual meeting and...s booth, the new line of "HealthView(TM)" Long-Ter...
(Date:11/9/2009)...tudy didn,t answer question of why this is so, how...s) -- After a lumpectomy, women with very dense br...he affected breast, a new study shows. , Breast... risk of developing breast cancer, and experts hav...sociated with an increased risk of cancer recurren...
(Date:11/9/2009)..., CAMBRIDGE, Mass., Nov. 9 Ab...d capabilities in delivering emergency management ...y awarded contracts to support the work of the Fed...f Regional Operations, the National Commission on ...itan Area Transit Authority (WMATA). The value of...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 2Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 3Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 4Health News:LG Electronics' New Line of HDTVs for Long-Term Care Facilities Signal Transition From Resident-Owned to Facility-Owned HDTVs 5Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3Health News:Abt Associates Expands Emergency Management Support Services To the Federal Government and Washington Metropolitan Area Transit Authority 2... HMS (Nasdaq: HMSY ) today announced that it had...hborhood Health Providers and Optima Health, a Sen... to its managed care portfolio. HMS will provide t...ge not previously known for its Medicaid members, ...
...Feb. 10 Zeus, Inc. is pleased to introduce its en...ccessible via http://www.zeusinc.com . , , With ... user-friendly resource for comprehensive informat...mation into four categories listed on the site,s h...
... New Epocrates Survey Reveals Patients May M... San Mateo, CA (PRWEB) Feb...to make more difficult economic choices than ever ...ake cutbacks on medications that could be harmful ...
...northern Illinois to use a new, cutting edge diagn...mprove patient care and outcomes. , , WOBURN, Mas...ounced OSF Saint Anthony Medical Center in Rockfor...physicians, pharmacists and nurses improve care an...
...., Feb. 10 Arete Therapeutics Inc. today,announce... AR9281, an orally-,administered soluble epoxide h...treatment of type 2 diabetes. S-EH is an enzyme in...81 Phase II clinical trial program breaks new grou...
... decline in procedure volume rate shows signs of s...ure volume up 48% , , Provides near-term financ...FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV ),...and 12 months ended December 31, 2008. , , Fourt...
Other Medicine News:Health News:HMS Awarded New Contracts for Managed Care Services 2Health News:Doctors Fear Patients Not Filling Prescriptions 2Health News:Doctors Fear Patients Not Filling Prescriptions 3Health News:OSF Saint Anthony Medical Center Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 2Health News:OSF Saint Anthony Medical Center Implements PNA FISH(R) Tests to Help Provide Best Care for Patients with Bloodstream Infections 3Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 2Health News:Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes 3Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 2Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 3Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 4Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 5Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 6Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 7Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 8Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 9Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 10Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 11Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 12Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 13Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 14Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 15Health News:LCA-Vision Announces Fourth Quarter and Full Year 2008 Financial Results 16...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
Moore Hyperopic Flap Conformer, 48 Diopter
...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
...gulation (ECP) is a surgical approach to glaucoma ...lized laser application. The ciliary body (which p...from the anterior or posterior segment, through th...asily and accurately identified utilizing endoscop...
Medicine Products: